Fiche personne
Coordonnées
CHRU de Nancy - Hôpitaux de Brabois
Service Hématologie
Rue du Morvan
54511 VANDOEUVRE LES NANCY Cedex
Territoire
Lorraine
Statut
Hospitalier
Recherche
Expertises :
- Clinique:Hématologie
- Recherche:Hématologie
Projets
Immunophysiopathologie de la surveillance anti-tumorale dans les traitements par CAR-T cells: déterminants moléculaires de la réponse et de l’échappement
2023 - Porteur du projet : Dr PAGLIUCA Simona
Publications
Inborn errors of immunity underlie clonal T cell expansions in large granular lymphocyte leukemia.
Bravo-Perez C, Gurnari C, Huuhtanen J, Kawashima N, Guarnera L, Mandala A, Williams ND, Haddad C, Witt M, Unlu S, Brady Z, Ogbue O, Orland M, Ahmed A, Kubota Y, Pagliuca S, Durmaz A, Mustjoki S, Visconte V, Maciejewski JP
J Clin Invest. 2025 05 1;135(9):
Current use of donor lymphocyte infusions after allogenic stem cell transplantation in Europe: a survey on behalf of the cellular therapy and immunobiology working party of the EBMT.
Santoro N, Schmid C, de Witte M, Roeven MWH, Potter V, Richardson D, Schroeder T, Válková V, Clesham K, Loron S, Passweg J, Besley C, Gruhn B, Hoogenboom JD, Mooyaart JE, Sanchez-Ortega I, Pagliuca S, Simonetta F, Battipaglia G, Guillaume T, Hazenberg MD, Malard F, Kuball J, Ruggeri A
Bone Marrow Transplant. 2025 03 23;:
The landscape of immune monitoring in CAR-T cell therapy: A comprehensive review and survey study by the Cellular Therapy and Immunobiology Working Party of the EBMT.
Pagliuca S, Malard F, Mooyaart JE, Daskalakis M, Gabellier L, Yakoub-Agha I, Ram R, Besley C, Forcade E, Vucinic V, Corral LL, Vydra J, von Tresckow B, Amat P, Amrolia P, Vandenberghe P, Stölzel F, Sica S, Rubio MT, Hoogenboom JD, Ortiz-Maldonado V, Nagler A, Kuball J, Chabannon C, Ruggeri A
Blood Rev. 2025 02 15;:101272
Differential Clinical and Immunological Impacts of Anti-T-Lymphocyte Globulin (ATLG) vs. Anti-Thymocyte Globulin (ATG) in Preventing Graft-Versus-Host Disease Post-Allogeneic Hematopoietic Stem Cell Transplantation: A Comparative Study.
Notarantonio AB, Morisset S, Piucco R, Pérès M, Boulangé L, Alitcher A, Brouard J, Monchablon L, Campidelli A, El Ouahabi S, Guisnel C, Moulin C, Kicki C, Roth-Guepin G, Feugier P, Bittencourt MC, Aarnink A, D'Aveni-Piney M, Hergalant S, Pagliuca S, Rubio MT
Am J Hematol. 2025 02 4;:
Incidence and risk factors of graft failure in allogeneic hematopoietic stem cell transplantation for mucopolysaccharidosis in a nationwide pediatric cohort. A study on behalf of the Francophone Society of Bone Marrow Transplantation and Cellular Therapy.
Danhardt L, Wiedemann A, Michel G, Dalle JH, Rialland F, Renard C, Jubert C, Maertens J, Sirvent A, Buchbinder N, Devalck C, Brichard B, Paillard C, Nguyen S, Paci A, Combarel D, Castelle M, Pagliuca S, Pochon C
EJHaem. 2024 12;5(6):1295-1300
Clonal hematopoiesis in large granular lymphocytic leukemia.
Kawashima N, Gurnari C, Bravo-Perez C, Kubota Y, Pagliuca S, Guarnera L, Williams ND, Durmaz A, Ahmed A, Dima D, Ullah F, Carraway HE, Singh A, Visconte V, Maciejewski JP
Leukemia. 2024 11 21;:
Role of molecular alterations in transplantation decisions for patients with primary myelofibrosis.
Luque Paz D, Gagelmann N, Benajiba L, Riou J, Salit RB, Orvain C, Schroeder T, Bories C, Gurnari C, Badbaran A, Boyer-Perrard F, Pagliuca S, Rautenberg C, Tavitian S, Panagiota V, Ianotto JC, Thol FR, Cayssials E, Heuser M, Rubio MT, Cassinat B, Daltro de Oliveira R, Sauter CS, Maciejewski JP, Reinhardt HC, Scott BL, Ugo V, Kröger N, Kiladjian JJ, Robin M
Blood Adv. 2024 11 19;:
HLA-lacking clones in aplastic anaemia: Adaptive or maladaptive?
Gurnari C, Lima ACM, Pagliuca S
Br J Haematol. 2024 08 26;:
Donor lymphocyte infusion after allogeneic haematopoietic cell transplantation for haematological malignancies: basic considerations and best practice recommendations from the EBMT.
Pagliuca S, Schmid C, Santoro N, Simonetta F, Battipaglia G, Guillaume T, Greco R, Onida F, Sánchez-Ortega I, Yakoub-Agha I, Kuball J, Hazenberg MD, Ruggeri A,
Lancet Haematol. 2024 06;11(6):e448-e458
Anti-T-lymphocyte globulin improves GvHD-free and relapse-free survival in myelofibrosis after matched related or unrelated donor transplantation.
Rathje K, Gagelmann N, Salit RB, Schroeder T, Gurnari C, Pagliuca S, Panagiota V, Rautenberg C, Cassinat B, Thol F, Robin M, Oechsler S, Heuser M, Rubio MT, Maciejewski JP, Reinhardt HC, Scott BL, Kröger N
Bone Marrow Transplant. 2024 05 21;:
Context-dependent role of trisomy 6 in myelodysplastic neoplasms and acute myeloid leukemia: a multi-omics analysis.
Awada H, Durmaz A, Kewan T, Ullah F, Dima D, Awada H, Pagliuca S, Meggendorfer M, Haferlach T, Gurnari C, Visconte V, Maciejewski JP
Leukemia. 2024 05 11;:
Risk factors for Nocardia infection among allogeneic hematopoietic cell transplant recipients: A case-control study of the Infectious Diseases Working Party of the European Society for Blood and Marrow Transplantation.
De Greef J, Averbuch D, Tondeur L, Duréault A, Zuckerman T, Roussel X, Robin C, Xhaard A, Pagliuca S, Beguin Y, Botella-Garcia C, Khanna N, Bourgeois AL, Praet JV, Ho A, Kröger N, Leprêtre SD, Roos-Weil D, Aljurf M, Blijlevens N, Blau IW, Carlson K, Collin M, Ganser A, Villate A, Lakner J, Martin S, Nagler A, Ram R, Torrent A, Stamouli M, Mikulska M, Gil L, Wendel L, Tridello G, Knelange N, de la Camara R, Lortholary O, Fontanet A, Styczynski J, Maertens J, Coussement J, Lebeaux D
J Infect. 2024 04 23;:106162
[Hematological toxicities post-CAR-T cells: Recommendations of the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)].
Alsuliman T, Aubrun C, Bay JO, Beguin Y, Bigenwald C, Brissot E, Chalandon Y, Chevallier P, Pagliuca S, Magro L, Srour M
Bull Cancer. 2024 04 16;:
Outbreak of carbapenemase-producing in an intensive care haematology department linked to a persistent wastewater reservoir in one hospital room, France, 2019 to 2022.
Regad M, Lizon J, Alauzet C, Roth-Guepin G, Bonmati C, Pagliuca S, Lozniewski A, Florentin A
Euro Surveill. 2024 04;29(14):
Paroxysmal nocturnal hemoglobinuria-related thrombosis in the era of novel therapies: a 2043 patient/years analysis.
Gurnari C, Awada H, Pagliuca S, Dima D, Ullah F, Kawashima N, Kubota Y, Colak C, Visconte V, Patel BJ, Dhillon V, Marneni N, Balasubramanian SK, Kishtagari A, Bat T, Maciejewski JP
Blood. 2024 03 21;:
Splenic irradiation for myelofibrosis prior to hematopoietic cell transplantation: A global collaborative analysis.
Gagelmann N, Hobbs GS, Campodonico E, Helbig G, Novak P, Schroeder T, Schneider A, Rautenberg C, Reinhardt HC, Bosques L, Heuser M, Panagiota V, Thol F, Gurnari C, Maciejewski JP, Ciceri F, Rathje K, Robin M, Pagliuca S, Rubio MT, Rocha V, Funke V, Hamerschlak N, Salit R, Scott BL, Duarte F, Mitrus I, Czerw T, Greco R, Kröger N
Am J Hematol. 2024 02 15;:
Diagnostic evaluation in bone marrow failure disorders: what have we learnt to help inform the transplant decision in 2024 and beyond?
Ciangola G, Santinelli E, McLornan DP, Pagliuca S, Gurnari C
Bone Marrow Transplant. 2024 01 30;:
Immune-driven clonal cell selection at the intersection among cancer, infections, autoimmunity and senescence.
Pagliuca S, Ferraro F
Semin Hematol. 2024 01 17;:
The many facets of immune-mediated thrombocytopenia: Principles of immunobiology and immunotherapy.
Moulinet T, Moussu A, Pierson L, Pagliuca S
Blood Rev. 2024 01;63:101141
Shifting Paradigms: The Case of Autologous Reconstitution after an Upfront Matched Unrelated Hematopoietic Cell Transplantation for Severe Acquired Aplastic Anemia in a Child.
Pochon C, Lubnau M, Pagliuca S
Medicina (Kaunas). 2023 10 24;59(11):
A new sequential conditioning regimen based on CPX- 351/Vyxeos ("Vyx-Seq") in patients with higher risk myelodysplastic syndromes.
Notarantonio AB, Roth-Guépin G, Bonmati C, Divoux M, Kicki C, Pagliuca S, Campidelli A, Rubio MT, D'Aveni-Piney M
Leuk Res. 2023 10 16;135:107405
Systemic complement activation influences outcomes after allogeneic hematopoietic cell transplantation: A prospective French multicenter trial.
Notarantonio AB, D'aveni-Piney M, Pagliuca S, Ashraf Y, Galimard JE, Xhaard A, Marçais A, Suarez F, Brissot E, Feugier P, Urien S, Bouazza N, Jacquelin S, Meatchi T, Bruneval P, Frémeaux-Bacchi V, Peffault De Latour R, Hermine O, Durey-Dragon MA, Rubio MT
Am J Hematol. 2023 07 22;:
Clonal evolution in aplastic anemia: failed tumor surveillance or maladaptive recovery?
Gurnari C, Pagliuca S, Maciejewski JP
Leuk Lymphoma. 2023 06 25;64(8):1389-1399
IPSS-M in myelodysplastic neoplasms arising from aplastic anemia and paroxysmal nocturnal hemoglobinuria.
Gurnari C, Prata PH, Catto LFB, Durmaz A, Larcher L, Sebert M, Allain V, Kewan T, Pagliuca S, Pinto AL, Inacio MCB, Hernandez L, Dhedin N, Caillat-Zucman S, Clappier E, Sicre de Fontbrune F, Voso MT, Visconte V, Peffault de Latour R, Soulier J, Socié G, Calado RT, Maciejewski JP
Blood. 2023 06 22;141(25):3122-3125
Leukemia relapse via genetic immune escape after allogeneic hematopoietic cell transplantation.
Pagliuca S, Gurnari C, Hercus C, Hergalant S, Hong S, Dhuyser A, D'Aveni M, Aarnink A, Rubio MT, Feugier P, Ferraro F, Carraway HE, Sobecks R, Hamilton BK, Majhail NS, Visconte V, Maciejewski JP
Nat Commun. 2023 05 31;14(1):3153
Molecular patterns identify distinct subclasses of myeloid neoplasia.
Kewan T, Durmaz A, Bahaj W, Gurnari C, Terkawi L, Awada H, Ogbue OD, Ahmed R, Pagliuca S, Awada H, Kubota Y, Mori M, Ponvilawan B, Al-Share B, Patel BJ, Carraway HE, Scott J, Balasubramanian SK, Bat T, Madanat Y, Sekeres MA, Haferlach T, Visconte V, Maciejewski JP
Nat Commun. 2023 05 30;14(1):3136
Current use of androgens in bone marrow failure disorders: a report from the Severe Aplastic Anemia Working Party of the European Society of Blood and Marrow Transplantation.
Pagliuca S, Kulasekararaj AG, Eikema DJ, Piepenbroek B, Iftikhar R, Satti TM, Griffin M, Laurino M, Kupesiz A, Bertrand Y, Fattizzo B, Yakoub-Agha I, Aljurf M, Corti P, Massaccesi E, Lioure B, Calabuig M, Klammer M, Unal E, Wu D, Chevallier P, Forcade E, Snowden JA, Ozdogu H, Risitano A, De Latour RP
Haematologica. 2023 05 18;:
Age-related immune cell dynamics influence outcomes after allogeneic haematopoietic cell transplantation.
Jandin A, Pochon C, Campidelli A, D'Aveni M, Kicki C, Notarantonio AB, Roth Guepin G, Mbuyi TA, Feugier P, Chastagner P, Schweitzer C, de Carvalho Bittencourt M, Rubio MT, Pagliuca S
Br J Haematol. 2023 04 24;:
Efficacy of haematopoietic stem cell boost as a rescue for poor graft function after haematopoietic stem cell transplantation: A multicentre retrospective study on behalf of the Francophone Society for Bone Marrow Transplantation and Cell Therapy (SFGM-TC
Gaffet M, Wiedemann A, Dalle JH, Bilger K, Forcade E, Robin M, Cornillon J, Labussière-Wallet H, Ceballos P, Bulabois CE, Loschi M, Orvain C, Rubio MT, Neven B, Pagliuca S, Pochon C
Br J Haematol. 2023 03 27;:
Impact of TP53 on outcome of patients with myelofibrosis undergoing hematopoietic stem cell transplantation.
Gagelmann N, Badbaran A, Salit RB, Schroeder T, Gurnari C, Pagliuca S, Panagiota V, Rautenberg C, Cassinat B, Thol FR, Wolschke C, Robin M, Heuser M, Rubio MT, Maciejewski JP, Reinhardt HC, Scott BL, Kröger N
Blood. 2023 03 20;:
A multimodal analysis of genomic and RNA splicing features in myeloid malignancies.
Durmaz A, Gurnari C, Hershberger CE, Pagliuca S, Daniels N, Awada H, Awada H, Adema V, Mori M, Ponvilawan B, Kubota Y, Kewan T, Bahaj WS, Barnard J, Scott J, Padgett RA, Haferlach T, Maciejewski JP, Visconte V
iScience. 2023 03 17;26(3):106238
Editorial: Endocrinological sequelae of hematopoietic stem cell transplantation.
Giudice V, Gurnari C, Pagliuca S, Castaldi MA, Selleri C
Front Endocrinol (Lausanne). 2023 02 14;14:1151213
Outcome prediction in myelodysplastic neoplasm undergoing hematopoietic cell transplant in the molecular era of IPSS-M.
Gurnari C, Gagelmann N, Badbaran A, Awada H, Dima D, Pagliuca S, D'Aveni-Piney M, Attardi E, Voso MT, Cerretti R, Wolschke C, Rubio MT, Maciejewski JP, Kröger N
Leukemia. 2023 01 28;:
Clinical and Molecular Determinants of Clonal Evolution in Aplastic Anemia and Paroxysmal Nocturnal Hemoglobinuria.
Gurnari C, Pagliuca S, Prata PH, Galimard JE, Catto LFB, Larcher L, Sebert M, Allain V, Patel BJ, Durmaz A, Pinto AL, Inacio MCB, Hernandez L, Dhedin N, Caillat-Zucman S, Clappier E, Sicre de Fontbrune F, Voso MT, Visconte V, Peffault de Latour R, Soulier J, Calado RT, Socié G, Maciejewski JP
J Clin Oncol. 2023 01 1;41(1):132-142
Digging into the HLA pockets: A new association with acute leukaemias.
Gurnari C, Pagliuca S
Br J Haematol. 2023 01;200(2):123-125
Molecular landscape of immune pressure and escape in aplastic anemia.
Pagliuca S, Gurnari C, Hercus C, Hergalant S, Nadarajah N, Wahida A, Terkawi L, Mori M, Zhou W, Visconte V, Spellman S, Gadalla SM, Zhu C, Zhu P, Haferlach T, Maciejewski JP
Leukemia. 2023 01;37(1):202-211
Comprehensive Transcriptomic Analysis of VISTA in Acute Myeloid Leukemia: Insights into Its Prognostic Value.
Pagliuca S, Gurnari C, Zhang K, Kewan T, Bahaj W, Mori M, Nautiyal I, Rubio MT, Ferraro F, Maciejewski JP, Wang L, Visconte V
Int J Mol Sci. 2022 11 28;23(23):
Filling the Gap: The Immune Therapeutic Armamentarium for Relapsed/Refractory Hodgkin Lymphoma.
Hazane Leroyer E, Ziegler C, Moulin C, Campidelli A, Jacquet C, Rubio MT, Feugier P, Pagliuca S
J Clin Med. 2022 11 6;11(21):
Screening in Sweet Syndrome With Hematological Neoplasms Reveals a Novel Association Between VEXAS and Chronic Myelomonocytic Leukemia.
Gurnari C, Mannion P, Pandit I, Pagliuca S, Voso MT, Maciejewski JP, Visconte V, Rogers HJ
Hemasphere. 2022 10;6(10):e775
A study of Telomerase Reverse Transcriptase rare variants in myeloid neoplasia.
Gurnari C, Wahida A, Pagliuca S, Durmaz A, Zawit M, Haferlach T, Maciejewski JP, Visconte V
Hematol Oncol. 2022 10;40(4):812-817
Pattern of somatic mutation changes after allogeneic hematopoietic cell transplantation for acute myeloid leukemia and myelodysplastic syndromes.
Hong S, Rybicki L, Gurnari C, Pagliuca S, Zhang A, Thomas D, Visconte V, Durrani J, Sobecks RM, Kalaycio M, Gerds AT, Carraway HE, Mukherjee S, Sekeres MA, Advani AS, Majhail NS, Hamilton BK, Patel BJ, Maciejewski JP
Bone Marrow Transplant. 2022 10;57(10):1615-1619
Individual HLA heterogeneity and its implications for cellular immune evasion in cancer and beyond.
Pagliuca S, Gurnari C, Rubio MT, Visconte V, Lenz TL
Front Immunol. 2022 09 5;13:944872
Rare germline alterations of myeloperoxidase predispose to myeloid neoplasms.
Kongkiatkamon S, Terkawi L, Guan Y, Adema V, Hasipek M, Dombrovski T, Co M, Walter W, Awada H, Parker Y, Hutter S, Pagliuca S, Gurnari C, Rogers HJ, Meggendorfer M, Lindner DJ, Haferlach T, Visconte V, LaFramboise T, Jha BK, Maciejewski JP
Leukemia. 2022 08;36(8):2086-2096
Molecular characterization of the histone acetyltransferase CREBBP/EP300 genes in myeloid neoplasia.
Kongkiatkamon S, Pagliuca S, Adema V, Nagata Y, Kerr CM, Walter W, Awada H, Hutter S, Gurnari C, Rogers HJ, Meggendorfer M, Saunthararajah Y, Haferlach T, Visconte V, Maciejewski JP
Leukemia. 2022 04;36(4):1185-1188
Personalized Risk Schemes and Machine Learning to Empower Genomic Prognostication Models in Myelodysplastic Syndromes.
Awada H, Gurnari C, Durmaz A, Awada H, Pagliuca S, Visconte V
Int J Mol Sci. 2022 03 3;23(5):
Eltrombopag inhibits TET dioxygenase to contribute to hematopoietic stem cell expansion in aplastic anemia.
Guan Y, Hasipek M, Jiang D, Tiwari AD, Grabowski DR, Pagliuca S, Kongkiatkamon S, Patel B, Singh S, Parker Y, LaFramboise T, Lindner D, Sekeres MA, Mian OY, Saunthararajah Y, Maciejewski JP, Jha BK
J Clin Invest. 2022 02 15;132(4):
TET2 mutations as a part of DNA dioxygenase deficiency in myelodysplastic syndromes.
Gurnari C, Pagliuca S, Guan Y, Adema V, Hershberger CE, Ni Y, Awada H, Kongkiatkamon S, Zawit M, Coutinho DF, Zalcberg IR, Ahn JS, Kim HJ, Kim DDH, Minden MD, Jansen JH, Meggendorfer M, Haferlach C, Jha BK, Haferlach T, Maciejewski JP, Visconte V
Blood Adv. 2022 01 11;6(1):100-107
The similarity of class II HLA genotypes defines patterns of autoreactivity in idiopathic bone marrow failure disorders.
Pagliuca S, Gurnari C, Awada H, Kishtagari A, Kongkiatkamon S, Terkawi L, Zawit M, Guan Y, LaFramboise T, Jha BK, Patel BJ, Hamilton BK, Majhail NS, Lundgren S, Mustjoki S, Saunthararajah Y, Visconte V, Chan TA, Yang CY, Lenz TL, Maciejewski JP
Blood. 2021 12 30;138(26):2781-2798
Current Opinions on the Clinical Utility of Ravulizumab for the Treatment of Paroxysmal Nocturnal Hemoglobinuria.
Gurnari C, Nautiyal I, Pagliuca S
Ther Clin Risk Manag. 2021 12 14;17:1343-1351
Alternative Splicing in Myeloid Malignancies.
Gurnari C, Pagliuca S, Visconte V
Biomedicines. 2021 12 6;9(12):
Is nature truly healing itself? Spontaneous remissions in Paroxysmal Nocturnal Hemoglobinuria.
Gurnari C, Pagliuca S, Kewan T, Bahaj W, Mori M, Patel BJ, Visconte V, Maciejewski JP
Blood Cancer J. 2021 11 27;11(11):187
Clonal trajectories and cellular dynamics of myeloid neoplasms with SF3B1 mutations.
Awada H, Kerr CM, Durmaz A, Adema V, Gurnari C, Pagliuca S, Zawit M, Kongkiatkamon S, Rogers HJ, Saunthararajah Y, Sekeres MA, Carraway H, Maciejewski JP, Visconte V
Leukemia. 2021 11;35(11):3324-3328
Monoclonal IgM gammopathy in adult acquired pure red cell aplasia: culprit or innocent bystander?
Gurnari C, Pagliuca S, Awada H, Zawit M, Patel BJ, Visconte V, Valent J, Rogers HJ, Maciejewski JP
Blood Cells Mol Dis. 2021 11;91:102595
Pegcetacoplan versus Eculizumab in PNH.
Gurnari C, Pagliuca S, Maciejewski JP
N Engl J Med. 2021 10 28;385(18):1725
A non-cytotoxic regimen of decitabine to treat refractory T-cell large granular lymphocytic leukemia.
Zawit M, Gurnari C, Pagliuca S, Awada H, Maciejewski JP, Saunthararajah Y
Clin Case Rep. 2021 09;9(9):e04533
Elastography improves accuracy of early hepato-biliary complications diagnosis after allogeneic stem cell transplantation.
Debureaux PE, Bourrier P, Rautou PE, Zagdanski AM, De Boutiny M, Pagliuca S, Sutra Del Galy A, Robin M, Peffault de Latour R, Plessier A, Sicre de Fontbrune F, Xhaard A, de Lima Prata PH, Valla D, Socié G, Michonneau D
Haematologica. 2021 09 1;106(9):2374-2383
Implication of PIGA genotype on erythrocytes phenotype in Paroxysmal Nocturnal Hemoglobinuria.
Gurnari C, Pagliuca S, Patel BJ, Awada H, Kongkiatkamon S, Terkawi L, Zawit M, Corey S, Lichtin AE, Carraway HE, Wahida A, Visconte V, Maciejewski JP
Leukemia. 2021 08;35(8):2431-2434
Clinical and basic implications of dynamic T cell receptor clonotyping in hematopoietic cell transplantation.
Pagliuca S, Gurnari C, Hong S, Zhao R, Kongkiatkamon S, Terkawi L, Zawit M, Guan Y, Awada H, Kishtagari A, Kerr CM, LaFramboise T, Patel BJ, Jha BK, Carraway HE, Visconte V, Majhail NS, Hamilton BK, Maciejewski JP
JCI Insight. 2021 07 8;6(13):
Vacuolization of hematopoietic precursors: an enigma with multiple etiologies.
Gurnari C, Pagliuca S, Durkin L, Terkawi L, Awada H, Kongkiatkamon S, Zawit M, Hsi ED, Carraway HE, Rogers HJ, Visconte V, Maciejewski JP
Blood. 2021 07 1;137(26):3685-3689
Novel invariant features of Good syndrome.
Gurnari C, Durrani J, Pagliuca S, Kishtagari A, Awada H, Kerr CM, Adema V, Kongkiatkamon S, Lichtin AE, Patel BJ, Visconte V, Sekeres MA, Cook JR, Maciejewski JP
Leukemia. 2021 06;35(6):1792-1796
Point-of-care ultrasound with handheld devices in hematology: a monocentric single-stage phase II study.
Pagliuca S, Bailly C, Talbot A, Bertinchamp R, Peyrony O, Elezi A, Bourrier P, Lengline E
Leuk Lymphoma. 2021 06;62(6):1379-1385
Friend or foe? The case of Wilms' Tumor 1 (WT1) mutations in acute myeloid leukemia.
Awada H, Durmaz A, Gurnari C, Kishtagari A, Zawit M, Pagliuca S, Visconte V
Blood Cells Mol Dis. 2021 05;88:102549
The Interactome between Metabolism and Gene Mutations in Myeloid Malignancies.
Gurnari C, Pagliuca S, Visconte V
Int J Mol Sci. 2021 03 19;22(6):
A Therapeutic Strategy for Preferential Targeting of TET2 Mutant and TET-dioxygenase Deficient Cells in Myeloid Neoplasms.
Guan Y, Tiwari AD, Phillips JG, Hasipek M, Grabowski DR, Pagliuca S, Gopal P, Kerr CM, Adema V, Radivoyevitch T, Parker Y, Lindner DJ, Meggendorfer M, Abazeed M, Sekeres MA, Mian OY, Haferlach T, Maciejewski JP, Jha BK
Blood Cancer Discov. 2021 03;2(2):146-161
Frequency and perturbations of various peripheral blood cell populations before and after eculizumab treatment in paroxysmal nocturnal hemoglobinuria.
Gurnari C, Graham AC, Efanov A, Pagliuca S, Durrani J, Awada H, Patel BJ, Lichtin AE, Visconte V, Sekeres MA, Maciejewski JP
Blood Cells Mol Dis. 2021 03;87:102528
Molecular Targeted Therapy in Myelodysplastic Syndromes: New Options for Tailored Treatments.
Pagliuca S, Gurnari C, Visconte V
Cancers (Basel). 2021 02 13;13(4):
Long-term outcomes and risk factor analysis of steroid-refractory graft versus host disease after hematopoietic stem cell transplantation.
Pagliuca S, Prata PH, Xhaard A, Frieri C, Giannoni L, Sutra Del Galy A, Brignier A, Sicre de Fontbrune F, Michonneau D, Dhedin N, Peffault de Latour R, Socié G, Robin M
Bone Marrow Transplant. 2021 01;56(1):38-49
Deciphering the Therapeutic Resistance in Acute Myeloid Leukemia.
Gurnari C, Pagliuca S, Visconte V
Int J Mol Sci. 2020 11 12;21(22):
Human-Derived α1-Antitrypsin is Still Efficacious in Heavily Pretreated Patients with Steroid-Resistant Gastrointestinal Graft-versus-Host Disease.
Giannoni L, Morin F, Robin M, Peyneau M, Schlageter MH, Desmier D, Pagliuca S, Sutra Del Galy A, Sicre de Fontbrune F, Xhaard A, Dhedin N, Moins-Teisserenc H, Peffault de Latour R, Socié G, Michonneau D
Biol Blood Marrow Transplant. 2020 09;26(9):1620-1626
Thrombocytapheresis and sequential chemotherapy for extreme symptomatic thrombocytosis secondary to myelofibrosis: a case report.
Debureaux PE, Brignier A, Soret-Dulphy J, Réa D, Michonneau D, Peffault de Latour R, Sicre de Fontbrune F, Pagliuca S, Parquet N, Prata HP, Marouf A, Xhaard A, Kiladjian JJ, Socié G, Robin M
Ann Hematol. 2020 04;99(4):897-898
A monocentric study of steroid-refractory acute graft-versus-host disease treatment with tacrolimus and mTOR inhibitor.
Xhaard A, Launay M, Sicre de Fontbrune F, Michonneau D, Sutra Del Galy A, Coman T, Pagliuca S, Dhedin N, Robin M, Peffault de Latour R, Socie G
Bone Marrow Transplant. 2020 01;55(1):86-92
Cord blood transplantation for bone marrow failure syndromes: state of art.
Pagliuca S, Ruggeri A, Peffault de Latour R
Stem Cell Investig. 2019 12 5;6:39
Epstein-Barr Virus-Associated Post-Transplantation Lymphoproliferative Disease in Patients Who Received Anti-CD20 after Hematopoietic Stem Cell Transplantation.
Pagliuca S, Bommier C, Michonneau D, Meignin V, Salmona M, Robin M, Prata PH, Xhaard A, de Fontbrune FS, Feghoul L, Dhedin N, de Latour RP, Caillat-Zucman S, Goff JL, Socié G
Biol Blood Marrow Transplant. 2019 12;25(12):2490-2500
Allogeneic reactivity-mediated endothelial cell complications after HSCT: a plea for consensual definitions.
Pagliuca S, Michonneau D, Sicre de Fontbrune F, Sutra Del Galy A, Xhaard A, Robin M, Peffault de Latour R, Socie G
Blood Adv. 2019 08 13;3(15):2424-2435
Aplastic Anemia & MDS International Foundation (AA&MDSIF): Bone Marrow Failure Disease Scientific Symposium 2018.
Becktell K, Berlyne D, Pagliuca S, Pommert L, Prata PH, Margolis D, de Latour RP, Dufour C, Pierri F
Leuk Res. 2019 05;80:19-25
Utility and Safety of Liver Biopsy in Patients with Undetermined Liver Blood Test Anomalies after Allogeneic Hematopoietic Stem Cell Transplantation: A Monocentric Retrospective Cohort Study.
Ruggiu M, Bedossa P, Rautou PE, Bertheau P, Plessier A, Peffault de Latour R, Robin M, Sicre de Fontbrune F, Pagliuca S, Villate A, Xhaard A, Socié G, Michonneau D
Biol Blood Marrow Transplant. 2018 12;24(12):2523-2531
Combined intensive immunosuppression and eculizumab for aplastic anemia in the context of hemolytic paroxysmal nocturnal hemoglobinuria: a retrospective analysis.
Pagliuca S, Risitano AM, De Fontbrune FS, Robin M, Iori AP, Marotta S, Michonneau D, Villate A, Desmier D, Socié G, De Latour RP
Bone Marrow Transplant. 2018 01;53(1):105-107
Long-Term Outcomes of Cord Blood Transplantation from an HLA-Identical Sibling for Patients with Bone Marrow Failure Syndromes: A Report From Eurocord, Cord Blood Committee and Severe Aplastic Anemia Working Party of the European Society for Blood and Mar
Pagliuca S, Peffault de Latour R, Volt F, Locatelli F, Zecca M, Dalle JH, Comoli P, Vettenranta K, Diaz MA, Reuven O, Bertrand Y, Diaz de Heredia C, Nagler A, Ghavamzadeh A, Sufliarska S, Lawson S, Kenzey C, Rocha V, Dufour C, Gluckman E, Passweg J, Ruggeri A
Biol Blood Marrow Transplant. 2017 11;23(11):1939-1948
B-cell non-Hodgkin lymphoma and pseudo-Gaucher cells in a lymph node fine needle aspiration.
Cozzolino I, Picardi M, Pagliuca S, Ciancia G, Luigia L, Pettinato G, Vetrani A
Cytopathology. 2016 04;27(2):134-6
Characteristics and outcomes of aplastic anemia in HIV patients: a brief report from the severe aplastic anemia working party of the European Society of Blood and Bone Marrow Transplantation.
Pagliuca S, Gérard L, Kulasekararaj A, Eapen M, Boutboul D, Martin H, Salvino MA, Knol-Bout C, Dufour C, Peffault de Latour R, Marsh J
Bone Marrow Transplant. 2016 02;51(2):313-5
Success of haploidentical hematopoietic stem cells transplantation in the treatment of graft failure.
Pagliuca S, Legendre H, Morin S, Rabian F, Naveau L, Zine M, Wang L, Marchand T, Coman T, Xhaard A, Ferry C, Robin M, Peffault De Latour R, Socié G, Sicre de Fontbrune F
Ann Hematol. 2016 01;95(2):353-4
Hematopoietic stem cell transplantation for aplastic anemia and paroxysmal nocturnal hemoglobinuria: current evidence and recommendations.
Marotta S, Pagliuca S, Risitano AM
Expert Rev Hematol. 2014 12;7(6):775-89
